The Ministry of Health has issued an urgent recall for weight-loss medications containing injectable drugs such as semaglutide, tirzepatide, cagrilintide, and liraglutide, among others.


Officials said these medications are primarily prescribed for treating type 2 diabetes and, in some cases, as supplements for managing overweight and obesity.


Health authorities warned that the drugs should only be prescribed by a licensed medical professional after an individual evaluation. Using them without medical supervision can cause serious side effects and put patients’ health at risk.


According to the ministry, these medications are being offered and sold on social media platforms, including Facebook, Instagram, TikTok, and X (formerly Twitter), by unauthorized individuals. In some cases, they are even being administered by people who are not qualified healthcare professionals.

  

Officials also noted that many of these medications require a controlled cold chain to maintain their effectiveness and quality. From importation and storage to distribution, they must be kept under proper temperature conditions. All injectable drugs must be stored and handled according to the manufacturer's instructions to ensure their safety and efficacy.

Anyone who has taken these medications and experiences allergic symptoms should seek immediate medical care at their local clinic or healthcare provider.

The ministry has ordered all unauthorized sellers and establishments to remove these drugs from the market. Consumers are encouraged to report any sales of these recalled products by calling the Ministry of Health at 2223-0333.

In a recent alert, health officials also ordered the recall of a popular Colgate toothpaste following reports of possible adverse health effects.

A.M. Costa Rica urges readers to share this public health warning within their communities.

---------------
Have you seen any of these weight-loss injectable drugs being sold in stores in your area? We would like to know your thoughts on this story. Send your comments to news@amcostarica.com